Effect of root canal sealer on pain following root canal treatment

Phase 3

• Conditions: Health Condition 1: K040- Pulpitis

• Registration Number: CTRI/2022/09/045690
• Lead Sponsor: SRM DENTAL COLLEGE

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 17 October 2022

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1. Good oral hygiene.

2. Patients belonging to ASA (American Society of Anesthesiologists) Category I and II.

3.Patients had not used any analgesic in last 7 days.

4. Patients had not used any antibiotic in last 7 days.

5. Patients diagnosed with symptomatic or asymptomatic irreversible pulpitis caused by deep carious lesion in the mandibular first or second molar teeth.

6. The presence of profusely pulp bleeding with a thick consistency, which is exposed during caries removing.

7. Patients who had healthy periapical tissues (confirmed with periapical radiography)

Exclusion Criteria

1. Patients who refuse to participate in this study.

2. Medically compromised patients (with immunosuppressive / systemic diseases, patients on medications).

3.Non-vital teeth.

4. The presence of advanced periodontal disease (probing depth > 4 mm).

5. The presence of open apex, presence of calcification, presence of resorption, root caries.

6. Patients who had multiple teeth requiring endodontic treatment.

7. Patients with allergic sensitivity to materials and agents that should be used during the root canal treatment.

8. Patients who had allergic sensitivity to local anesthetics.

9. Patients who had systemic or allergic sensitivty for the NSAIDs.

10. Pregnant patients and patients in lactation period.

11. Overfilling (extrusion of the gutta-percha or sealer beyond the radiographic apex) or short filing ( > 2 mm short from the radiographic apex).

12. The teeth with extensive coronal destruction that need a core build-up.

13. Retreatment cases.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Reduction of pain when bioceramic sealer is usedTimepoint: 6, 12, 24 and 48 hours, and 3, 5, and 7 days.

Secondary Outcome Measures

Name	Time	Method
Intake of analgesic when bioceramic sealer is usedTimepoint: 6, 12, 24 and 48 hours, and 3, 5, and 7 days.